LINC 2014 Programme

Find all topics and speakers listed below.

Main Arena 1

24 events
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Challenges of the SFA – stent properties and design and deployment techniques affecting outcomes

    Chairman:
    Johannes Lammer, Dierk Scheinert
    Moderator:
    Stefan Müller-Hülsbeck, Martin Funovics, Richard Rapoza
    1. -

      Introduction by the chairman

    2. -

      Stent design, radial outforce and oversizing – do they affect outcomes? Research data

        Martin Funovics
    3. -

      How to optimize outcomes in the SFA?

        Stefan Müller-Hülsbeck
    4. -

      Live case transmission from Leipzig

    5. -

      BVS – the future of PAD treatment

        Richard Rapoza
    6. -

      BVS in the SFA – 1 year Esprit results

        Johannes Lammer
    7. -

      Live case transmission from Aalst

    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    A decade of innovation: Advances and future perspectives in cardiovascular medicine

    Chairman:
    Dierk Scheinert, Giancarlo Biamino
    Moderator:
    Frank Criado, Giovanni Torsello, Christoph Nienaber, William Gray, Krishna Rocha-Singh
    1. -

      The evolution of endovascular aortic repair – How far have we come?

        Frank Criado
    2. -

      Low profile solution for abdominal aortic aneurysms

    3. -

      INCRAFT AAA stent graft: 2 year results from the INNOVATION trial

        Giovanni Torsello
    4. -

      The European Ovation 500 patients registry

        Dierk Scheinert
    5. -

      Live case transmission from Leipzig

    6. -

      Should endovascular repair finally be considered the primary treatment for Type B aortic dissections?

        Christoph Nienaber
    7. -

      Pioneering techniques in cardiovascular medicine

    8. -

      Advanced interventional treatment concepts for structural heart disease: Update on TAVI and beyond

        Gerhard Schuler
    9. -

      TAVI with cerebral protection – video case

        Stephan Haußig
    10. -

      REDUCE-HTN trial: Renal denervation with a percutaneous bipolar RF balloon catheter in patients with resistant hypertension

        Dierk Scheinert
    11. -

      Live case transmission from Berlin

    12. -

      Renal denervation therapy – what we know and what we don't know

        Krishna Rocha-Singh
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Global perspective - when to use drug-eluting devices for the SFA

    Chairman:
    Michael Dake
    Moderator:
    Marc Bosiers
    1. -

      Introduction and Zilver PTX – 4 year results

        Michael Dake
    2. -

      Live case transmission from Leipzig

    3. -

      US Zilver PTX experience

    4. -

      Live case transmission from Aalst

    5. -

      Leave nothing behind – reality YES

        Dierk Scheinert
    6. -

      Leave nothing behind – reality NOT

        Marc Bosiers
    7. -

      How I use Zilver PTX in my practice

        Sebastian Sixt
    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    Lunch

  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Prime time for drug eluting balloons in femoro-poplitealinterventions? Hard facts and outstanding questions

    Chairman:
    Dierk Scheinert
    Moderator:
    Erich Minar, William Gray, Thomas Zeller, Sebastian Sixt, Marianne Brodmann
    1. -

      Introduction by the chairman

    2. -

      The IN.PACT SFA evidence overview and take-homes

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      The cost-effectiveness value of DEB in femoro-popliteal revascularization

        Thomas Zeller
    5. -

      From evidence to practice: how DEBs fit my daily work

        Marianne Brodmann
    6. -

      Live case transmission from Leipzig

    7. -

      Role and requisites of stents in the DEB era

        Sebastian Sixt
    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    A decade of innovation: Current treatment, remaining challenges and future concepts for the femoropopliteal arteries

    Chairman:
    John Laird, Karl-Ludwig Schulte
    Moderator:
    Sumaira Macdonald, Chris Metzger, Hans Martin Gißler, Patrick Peeters
    1. -

      Stenting of the superficial femoral and popliteal artery: How good is the benchmark after years of optimisation?

        Erich Minar
    2. -

      2-year update on the SUPERB-study using a interwoven biomimetic nitinol stent in the SFA

        Kenneth Rosenfield
    3. -

      TASC D and beyond – 12 months results on the longest endoluminal bypass

        Thomas Zeller
    4. -

      Durability + Study: 12 months results

        Patrick Peeters
    5. -

      Latest clinical trials on drug-elution in femoropopliteal arteries

    6. -

      LEVANT II RCT

        Dierk Scheinert
    7. -

      PACIFIER RCT – 24 months update

        Michael Werk
    8. -

      My insights from DEB-RCTs: Breakthrough technology or just another tool in the box?

        Johannes Lammer
    9. -

      Live case transmission from Leipzig

    10. -

      Drug-elution with or without scaffolds for long lesions

        Thomas Zeller
    11. -

      Real world use of DEB in long femoropopliteal lesions – 2 year results

        Andrej Schmidt
    12. -

      Assessment of calcium burden and calcium effect on drug elution

        Fabrizio Fanelli
    13. -

      Less is more? Are more focal scaffolds the better solution?

        Renu Virmani
    14. -

      The concept of focal stenting – Lessons learned and future perspectives

        Klaus Amendt
    15. -

      TOBA study – initial results of the TACK system

        Thomas Zeller
    16. -

      Bioresorbable drug-eluting scaffolds for the SFA – new developments: The Elixir Medical program

        Dierk Scheinert
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Anti-restenosis treatment for SFA: Defining the new standard of care

    Chairman:
    Yann Gouëffic
    Moderator:
    Patrick Peeters, Stephan Duda, Arne Schwindt, Thomas Zeller
    1. -

      Introduction by the chairman

    2. -

      Evidence to support a standard of care: ILLUMENATE study series

        Patrick Peeters
    3. -

      ILLUMENATE First in human 12-month outcomes

        Stephan Duda
    4. -

      Live case transmission from Leipzig

    5. -

      Approaching the complex SFA lesion with stents

        Arne Schwindt
    6. -

      Live case transmission from Palermo

    7. -

      Beating the plaque burden with directional arterectomy: DEFINITIVE AR acute outcomes

        Thomas Zeller
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Renal denervation – insights and applications

    Chairman:
    Dierk Scheinert
    Moderator:
    Christoph Nienaber, Piero Montorsi, Stefan Müller-Hülsbeck
    1. -

      Introduction by the chairman

    2. -

      Procedural and anatomic considerations

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      Co-morbid states impacted by renal denervation – a review

        Stefan Müller-Hülsbeck
    5. -

      VESSIX renal denervation system, clinical update and future direction

    6. -

      Pre-recorded case

        Piero Montorsi
    7. -

      Referral pathways – patient centered teamwork

        Christoph Nienaber
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    A decade of innovation: Pioneering approaches and remaining challenges for limb salvage in CLI

    Chairman:
    Dierk Scheinert
    Moderator:
    Krishna Rocha-Singh, Thomas Zeller, Iris Baumgartner, Marc Bosiers, Frank Vermassen
    1. -

      Angiosome based treatment strategies in full BTK 3-vessel occlusion

        Vlad Alexandrescu
    2. -

      Live case transmission from Leipzig

    3. -

      Below-the-ankle arterial disease: when to treat and how

        Roberto Ferraresi
    4. -

      Latest clinical trials on drug-eluting for CLI

    5. -

      The rationale for drug-elution in BTK treatment – what is the requirement for vessel patency?

        Frank Vermassen
    6. -

      DEB vs. DES in CLI: Results from the IDEAS I RCT

        Panagiotis Kitrou
    7. -

      PES BTK 70 study: 6 months results with a self-expanding paclitaxel eluting stent in BTK

        Marc Bosiers
    8. -

      Clinical outcome after BTK DEB treatment in CLI - the Leipzig single centre experince - A. Schmidt

        Andrej Schmidt
    9. -

      Biolux PII - a randomized clinical trial of DEB vs. PTA for infrapopliteal disease: 6 months angiographic follow-up

        Marianne Brodmann
    10. -

      IN.PACT DEB in CLI and diabetes: 2 year results with the DEBATE BTK randomized clinical trial

        Francesco Liistro
    11. -

      DEB vs. PTA for infrapopliteal revascularisation: 12 months results from the IN.PACT DEEP randomized trial

        Thomas Zeller
    12. -

      A review of clinical evidence on CLI

        Krishna Rocha-Singh
    13. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Unique technologies for the treatment of peripheral artery disease

    Chairman:
    Johannes Lammer
    Moderator:
    Peter Soukas, Dennis Gable, Michael Piorkowski, Po-Jen Ko
    1. -

      Introduction by the chairman

    2. -

      Demonstrated clinical success and technical considerations for covered stents in the SFA: Key learning from the VIPER and VIASTAR studies

        Dennis Gable
    3. -

      Live case transmission from Leipzig

    4. -

      Viabahn for in-stent restenosis treatment

        Po-Jen Ko
    5. -

      Live case transmission from Leipzig

    6. -

      12 months single center patency data for dual component bare metal stent in the SFA

        Michael Piorkowski
    7. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Lunch symposium: How do you treat your challenging aortoiliac stenotic lesion?

    Chairman:
    Dierk Scheinert
    Moderator:
    Gustavo Oderich, Piotr Kasprzak, Peter Goverde
    1. -

      Introduction by the chairman

    2. -

      Expanding the role of covered stents in aortoiliac lesions

        Gustavo Oderich
    3. -

      Aortoiliac disease; one year multi-center clinical update

        Piotr Kasprzak
    4. -

      Live case transmission from Leipzig

    5. -

      CERAB: flow-dynamic study and one year results

        Peter Goverde
  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Lutonix drug coated balloons – clinical evidence and real world applications

    Chairman:
    Marianne Brodmann
    Moderator:
    Dierk Scheinert, Michael Lichtenberg, Francesco Liistro
    1. -

      Introduction by the chairman

    2. -

      LEVANT II study design and subgroup analysis

        Dierk Scheinert
    3. -

      Single center experience global SFA registry

        Michael Lichtenberg
    4. -

      Live case transmission from Berlin

    5. -

      BTK applications and Lutonix BTK clinical trial

        Marianne Brodmann
    6. -

      The benefit of drug coated balloons in complex BTK cases

        Francesco Liistro
    7. -

      Pre-clinical safety data and technology review

        Renu Virmani
    8. -

      A Single Center Experience with Lutonix

        Peter von Bilderling
    9. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    VIVA @ LINC - Carotid bifurcation disease: pressing new dilemmas and pushing the field forward

    Chairman:
    Peter Schneider
    Moderator:
    Mehdi Shishehbor, John Laird, Tony Das, Marco Roffi, Carlo Setacci
    1. -

      Presentation of the Vascular Career Advancement Award, soponsored by VIVA and LINC. 2013/2014 Awardees: M. Shishehbor, Cleveland, USA and M. Werner, Vienna, Austria.

    2. -

      The case of repair of critical, but asymptomatic carotid stenosis

    3. -

      Live case transmission from Columbus

    4. -

      Future carotid trials and endpoints. This is how we make progress

        Tony Das
    5. -

      CAS is the right choice for patients who also require coronary bypass

        Mehdi Shishehbor
    6. -

      Live case transmission from Columbus

    7. -

      Advances in stents, protection devices, and patient selection will make CAS safer

        John Laird
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Interventional techniques for visceral and renal arteries

    Chairman:
    Johannes Lammer, Barry Katzen
    Moderator:
    Felix Mahler, Steve Ramee, Ramon Varcoe, Sebastian Debus, Thomas Rand
    1. -

      Comparison of covered stents and bare metal stents for treatment of chronic mesenteric ischemia

        Gustavo Oderich
    2. -

      Is chronic visceral ischemia an underdiagnosed phenomenon? Interventional techniques and outcome

        Craig Walker
    3. -

      Live case transmission from Palermo

    4. -

      Management of renal and visceral artery aneurysms

        Barry Katzen
    5. -

      Live case transmission from Leipzig

    6. -

      The case for renal artery revascularization: My take away from all the clinical trials including CORAL

        Steve Ramee
    7. -

      Discussion

  • Thursday, January 30th: - , Main Arena 1

    Symposium: Vascular mimetic technology – Design, engineering, and clinical outcomes

    Chairman:
    Dierk Scheinert, Peter Goverde
    Moderator:
    Chris Metzger, Kenneth Rosenfield, Jan Peter Goltz
    1. -

      Introduction by the chairman

    2. -

      Vascular mimetic technology

        Peter Goverde
    3. -

      Live case transmission from Bad Krozingen

    4. -

      Clinical results from the SUPERB and Supera 500

        Dierk Scheinert
    5. -

      Real world data with Supera in the superficial femoral artery and popliteal artery – Results and clinical experience from the AURORAA trial

        Peter Goverde
    6. -

      Real world data with Supera in the superficial femoral artery and popliteal artery – Treatment of popliteal artery lesions in patients with CLI

        Jan Peter Goltz
    7. -

      Live case transmission from Leipzig

  • Thursday, January 30th: - , Main Arena 1

    A decade of innovation: Remaining challenges and future prospectives for the femoropopliteal arteries

    Chairman:
    Kenneth Rosenfield
    Moderator:
    Ralf Langhoff, Marc Bosiers, Craig Walker, Peter Soukas, Dai-Do Do
    1. -

      The Zilver PTX registry ISR subanalysis

        Michael Dake
    2. -

      2-year results of DEB for treatment of ISR

        Eugenio Stabile
    3. -

      The Debate-ISR study: 2-year data

        Francesco Liistro
    4. -

      Live case transmission from Leipzig

    5. -

      Latest clinical trials on treatment of in-stent restenosis

    6. -

      RELINE - randomized clinical trial: Viabahn covered stents vs. PTA

        Koen Deloose
    7. -

      The FAIR - randomized clinical trial of DEB vs. PTA for SFA-ISR

        Hans Krankenberg
    8. -

      Live case transmission from Bad Krozingen

    9. -

      Initial experience with DEB in occluded lower limb bypass

        Konstantinos Katsanos
    10. -

      BioMimics 3D - advanced stent design: Concept to randomised controlled trial

        Thomas Zeller, Via satellite from Bad Krozingen
    11. -

      Discussion and conclusion

  • Thursday, January 30th: - , Main Arena 1

    Symposium: Treatment of arterial and venous occlusions – "Why do I use mechanical debulking?"

    Chairman:
    Miroslav Bulvas
    Moderator:
    Eberhard Wedell, Steven Kum, Sven Bräunlich, Torsten Fuß, Thomas Heller
    1. -

      Introduction by the chairman

    2. -

      Rotarex in daily practice – indications and results of the last 10 years

        Sven Bräunlich
    3. -

      Live case transmission from Leipzig

    4. -

      Treatment of long segment ISR. Rotarex plus DEB improves the outcome

        Torsten Fuß
    5. -

      Recanalisation of venous thrombosis. Is there an advantage in using a mechanical thrombectomy system?

        Thomas Heller
    6. -

      Live case transmission from Bad Krozingen

    7. -

      Discussion and conclusion

  • Thursday, January 30th: - , Main Arena 1

    Lunch

  • Thursday, January 30th: - , Main Arena 1

    TCT @ LINC: Pioneering techniques and future perspectives in endovascular interventions. „Leaving no metal behind“ – the concept for the future?

    Chairman:
    William Gray
    Moderator:
    Gunnar Tepe, Renu Virmani, Sumaira Macdonald, Hans Martin Gißler, Tony Das, Johannes Lammer
    1. -

      Current evidence and clinical utility of atherectomy systems

        William Gray
    2. -

      The Phoenix Atherectomy System: My initial experience with the next generation of peripheral atherectomy

        Thomas Zeller, Via satellite from Bad Krozingen
    3. -

      Directional atherectomy + DEB: Early insights from the Definitive AR study

        Gunnar Tepe
    4. -

      The SHOCKWAVE lithoplasty concept for calcified lesions – initial clinical experience

        Marianne Brodmann
    5. -

      Live case transmission from Bad Krozingen

    6. -

      The only solution for peripheral arteries is to avoid permanent implants – bioabsorbable scaffolds will be the future!

        Renu Virmani
    7. -

      Latest generation bioabsorbable technology – how to make it work

        Dierk Scheinert
    8. -

      Live case transmission from Leipzig

    9. -

      Chocolate BAR: Chocolate PTA in a broad range of patients with peripheral arterial disease, a prospective post-marketing study

        Tony Das
  • Thursday, January 30th: - , Main Arena 1

    Scrub in with the experts: Advanced techniques for carotid revascularisation

    live from Münster:
    Arne Schwindt
    live from Palermo:
    Fausto Castriota
    Chairman:
    Giovanni Torsello
    Moderator:
    Sumaira Macdonald, Max Amor, Dariusz Dudek, Paolo Rubino
    1. -

      Flash presentation: Critical literature appraisal on carotid artery stenting

        Sumaira Macdonald
    2. -

      Flash presentation: Patient selection, techniques, and armamentarium: Lessons learned after CREST

        William Gray
    3. -

      Flash presentation: Pre-clinical and first clinical experiences with Micromesh carotid stent

        Max Amor
    4. -

      Flash presentation: Proximal protection during CAS

        Piotr Odrowaz-Pieniazek
  • Thursday, January 30th: - , Main Arena 1

    The last frontier: Endovascular interventions in the common femoral and popliteal arteries

    Chairman:
    Barry Katzen
    Moderator:
    Reza Ghotbi, Patrick Peeters, Chris Metzger, Ralph-Ingo Rückert, Peter Schneider
    1. -

      The TECCO trial: results of the French multicentric randomized clinical trial comparing endovascular vs. open surgery for the treatment of common femoral artery de novo lesions

        Yann Gouëffic
    2. -

      Live case transmission from Bad Krozingen

    3. -

      Anatomical and biomechanical specifics of the popliteal artery

        Stefan Müller-Hülsbeck
    4. -

      Clinical trial update: ETAP randomized clinical trial: 24 months update

        Thomas Zeller, Via satellite from Bad Krozingen
    5. -

      Clinical trial update: The Durability Pop study – 2 year results

        Patrick Peeters
    6. -

      The Leipzig SUPERA Popliteal artery stent registry - long-term results

        Johannes Schuster
    7. -

      Entrapment syndrome of the popliteal artery – diagnostic work-up and treatment

        Ralph-Ingo Rückert
    8. -

      Live case transmission from Leipzig

    9. -

      Endovascular repair of popliteal artery aneurysms: Technical considerations, patient selection, and outcome

        Barry Katzen
  • Friday, January 31st: - , Main Arena 1

    Join us for brunch!

  • Friday, January 31st: - , Main Arena 1

    Critical issues in aortic endografting

    Chairman:
    Michel Makaroun, Roberto Chiesa
    Moderator:
    Marc van Sambeek, Steven Kum, Eric Verhoeven, Giovanni Torsello, Armando Lobato
    1. -

      Live case transmission from Münster

    2. -

      EVAR improves outcomes of elective and ruptured AAA

        Marc Schermerhorn
    3. -

      Scientific and clinical value of contemporary EVAR post market registries: The ENGAGE case example

        Hence Verhagen
    4. -

      Long-term results with the Endurant stentgraft: The Muenster single center experience with 700+ patients

        Theodosios Bisdas
    5. -

      The real life GORE® GREAT registry: Latest clinical evidence and ongoing modules

        Patrick Vriens
    6. -

      TREOVANCE in EVAR: Latest results on ADVANCE, BENEFIT and RATIONALE clinical studies

        Vicente Riambau
    7. -

      Multicenter registry to evaluate the performance of chimney and periscope grafts

        Konstantinos Donas
    8. -

      Thinking out of the box: innovative solutions for challenging EVAR cases - Nellix and beyond

        Dittmar Böckler
    9. -

      Live case transmission from Leipzig

    10. -

      One year experience with complete endovascular repair of thoracoabdominal aneurysms by compartmentalizing aortic flow

        Patrick Kelly
    11. -

      Custom-made vs. off-the-shelf multibranched endografts for endovascular repair of TAAA

        Martin Austermann, Via satellite from Münster
    12. -

      My experience with parallel graft techniques as an off-the-shelf solution for complex aortic aneurysms

        Armando Lobato
    13. -

      Update on understanding and management of PAU and IMH

        Frank Criado
    14. -

      Retrograde Type A dissections after EVAR – insights from surgical re-do procedures

        Michael Borger
    15. -

      Live case transmission from Münster

    16. -

      Prevention and treatment of Type I endoleaks with the Aptus system

        Piotr Kasprzak
    17. -

      Late Type I endoleak are better treatable by chimneys

        Konstantinos Donas
    18. -

      Innovative system for iliac branch procedures: The new GORE® EXCLUDER® iliac branch endoprosthesis

        Fabio Verzini
    19. -

      9-year experience with the use of iliac side branch devices in more than 160 patients

        Giovanni Torsello
  • Friday, January 31st: - , Main Arena 1

    After completion of the programme, buses will leave from the congress venue directly to the airport, the trainstation, as well as back to the city center.